A Game-Changer For Pfizer Inc. (PFE)

3 Drug Launches You Need to Know in 2013: Pfizer, NPS Pharma, Ariad PharmaThe wealth-building power of compound interest will never cease to amaze me. It’s a story of patience and attention to detail, where small, short-term differences add up to massive divergence over decades. And in the end, the biggest winners don’t always deliver the fattest share-price returns.

Biopharma giant Pfizer Inc. (NYSE:PFE) just reported a disappointing first quarter. Pfizer Inc. (NYSE:PFE) share prices fell as much as 4.8% on a generally flat market day, making the stock the worst performer on the Dow Jones Industrial Average (Dow Jones Indices:.DJI) today — by a long shot. The company missed Wall Street’s revenue and earnings targets as key products started falling out of patent protection

But Pfizer Inc. (NYSE:PFE)’s stock still trades less than 6% below recently set all-time highs, and management boosted dividend payments by 9% last quarter. The shares offer a meaty 3.3% dividend yield, even at these skyrocketing prices. And that dividend muscle is what turns Pfizer Inc. (NYSE:PFE)’s proven cash machine into a market-crushing investment vehicle.

PFE Dividend Chart

PFE Dividend data by YCharts.

Reinvesting Pfizer’s dividends is a winning strategy. That way, you put some serious distance between dividend-adjusted returns and the Dow’s gains. Pfizer even beats the total return of fellow Dow member Merck & Co., Inc. (NYSE:MRK).

And here’s why: Pfizer Inc. (NYSE:PFE) did slash dividend payouts in response to the 2008 and 2009 global economic crisis, but it has boosted its policy every year since then. Merck & Co., Inc. (NYSE:MRK) has provided just two dividend boosts in the last four years. All told, Pfizer’s payouts have jumped 50% since the post-crisis rock bottom, while Merck’s only gained 13%.

Not only that, but Pfizer Inc. (NYSE:PFE)’s dividends still have more room to grow than Merck & Co., Inc. (NYSE:MRK)’s. Both companies pocket a generous share of their free cash flows, but Pfizer uses a smaller portion of its cash for dividend payments. And unlike Merck’s, Pfizer’s cash funding never dried out, even at the height of that old crisis.

PFE Cash Div. Payout Ratio TTM Chart

PFE Cash Div. Payout Ratio TTM data by YCharts.

These are the details that make income investors sleep soundly at night with some Pfizer Inc. (NYSE:PFE) stock under their pillows. Don’t let one disappointing quarter scare you away from this hulking generator and sharer of cash.

The article How Dividends Change the Game for Owners of Pfizer Stock originally appeared on Fool.com and is written by Anders Bylund.

Fool contributor Anders Bylund holds no position in any company mentioned. Check out Anders’ bio and holdings or follow him on Twitter and Google+.The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

The 10 Longest Wars of All Time

The 13 Worst Looking Foods that Taste Great

The 6 Most Gruesome Injuries Suffered During a Sports Match

The 20 Biggest Contracts in MLB History

The 7 Worst Blown Calls in Sports History

7 Free Ways to Advertise Your Business Online

The 18 Best R&B Songs of the 90’s

The 10 Most Dangerous States to be a Cop

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!